AstraZeneca Can't Duck Patent Claim Over Symbicort Inhaler
A Texas federal judge ruled Tuesday that Accuhale LLC's suit alleging AstraZeneca LP infringed a patent for a pressurized metered-dose inhaler indicator could move forward, saying AstraZeneca hadn't proven that the...To view the full article, register now.
Already a subscriber? Click here to view full article